Journal
CURRENT TOPICS IN MEDICINAL CHEMISTRY
Volume 8, Issue 10, Pages 888-904Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156802608784911626
Keywords
kinesin; inhibitor; kinesin spindle protein; KSP; Eg5; cancer
Categories
Ask authors/readers for more resources
Kinesin spindle protein (KSP), a mitotic kinesin responsible for bipolar spindle establishment and maintenance, is currently the target of intense research for the development of novel anticancer therapeutics. Several inhibitors of KSP have progressed into clinical trials and many others are in preclinical development. A majority of these inhibitors are ATP-uncompetitive and bind in an allosteric loop L5 binding pocket, but recently, inhibitors with an alternative mechanism of action (ATP-competitive) have also been identified and characterized. In this review, an update of the clinical trial results with ATP-uncompetitive KSP inhibitors is provided and recent progress in the identification of additional KSP inhibitors is discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available